B. Juran

发表

Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia.

H. Sather, G. Reaman, F. Uckun, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of circulating cell-free DNA in cholestatic liver disease using liver-specific methylation markers

Raymond M. Moore, Zhifu Sun, K. Lazaridis, 2021, BMC Gastroenterology.

American Gastroenterological Association future trends committee report: the application of genomic and proteomic technologies to digestive disease diagnosis and treatment and their likely impact on gastroenterology clinical practice.

K. Lazaridis, B. Juran, 2005, Gastroenterology.

MERICAN GASTROENTEROLOGICAL ASSOCIATION merican Gastroenterological Association Future Trends ommittee Report : The Application of Genomic and Proteomic echnologies to Digestive Disease Diagnosis and Treatment nd Their Likely Impact on Gastroenterology Clinical Practice

B. Juran, Onstantinos N. Lazaridis, 2022 .

Carriage of a tumor necrosis factor polymorphism amplifies the cytotoxic T‐lymphocyte antigen 4 attributed risk of primary biliary cirrhosis: Evidence for a gene–gene interaction

K. Siminovitch, J. Larson, E. Atkinson, 2010, Hepatology.

Reduced coffee consumption among individuals with primary sclerosing cholangitis but not primary biliary cirrhosis.

M. de Andrade, E. Atkinson, C. Lammert, 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Environmental Factors in Primary Biliary Cirrhosis

K. Lazaridis, B. Juran, 2014, Seminars in Liver Disease.

DNA methylation profile of liver tissue in end-stage cholestatic liver disease

Raymond M. Moore, G. Gores, N. LaRusso, 2022, Epigenomics.

Primary biliary cirrhosis.

K. Lazaridis, B. Juran, Douglas L. Nguyen, 2010, Best practice & research. Clinical gastroenterology.

Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease

Mariza de Andrade, Andre Franke, Wolfgang Lieb, 2016, Nature Genetics.

Induced Pluripotent Stem Cells From Subjects With Primary Sclerosing Cholangitis Develop a Senescence Phenotype Following Biliary Differentiation

N. LaRusso, V. Shah, J. Heimbach, 2021, Hepatology communications.

Bile Acid Profiles in Primary Sclerosing Cholangitis and Their Ability to Predict Hepatic Decompensation

G. Gores, T. Karlsen, Chang Hu, 2020, Hepatology.

Doublecortin domain containing protein 2 (DCDC2) genetic variants in primary sclerosing cholangitis.

Raymond M. Moore, N. LaRusso, K. Lazaridis, 2017, Journal of hepatology.

A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease

N. Chalasani, E. Atkinson, M. Andrade, 2015, Alimentary pharmacology & therapeutics.

Omics Interrogation of Primary Sclerosing Cholangitis

B. Juran, A. Ali, Bryan M. McCauley, 2021 .

Association Between HLA Haplotypes and Increased Serum Levels of IgG4 in Patients With Primary Sclerosing Cholangitis.

T. Karlsen, K. Boberg, N. L. Berntsen, 2015, Gastroenterology.

An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

Alexander E. Lopez, Aaron M. King, Andrew L Blumenfeld, 2021, Journal of hepatology.

Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants.

K. Siminovitch, C. Amos, X. Gu, 2009, The New England journal of medicine.

Increased prevalence of antimitochondrial antibodies in first‐degree relatives of patients with primary biliary cirrhosis

E. Dickson, M. de Andrade, G. Petersen, 2007, Hepatology.

Studying the Exposome to Understand the Environmental Determinants of Complex Liver Diseases

G. Miller, D. Walker, K. Lazaridis, 2019, Hepatology.

Is the FXR the fix for cholesterol gallstone disease?

K. Lazaridis, B. Juran, 2005, Hepatology.

Liquid Biopsy in Cholestatic Liver Disease Using Hepatocyte-Specific Methylation Markers

Raymond M. Moore, K. Lazaridis, B. Juran, 2021 .

Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci

Søren Brunak, Buhm Han, Andres Metspalu, 2016, Nature Genetics.

Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease

T. Karlsen, K. Boberg, A. Bergquist, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Applying genomics to the study of complex disease.

Konstantinos N Lazaridis, K. Lazaridis, Brian D Juran, 2007, Seminars in liver disease.

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

Judy H. Cho, Nadezhda T. Doncheva, O. Andreassen, 2013, Nature Genetics.

Genomics in the post-GWAS era.

Konstantinos N Lazaridis, K. Lazaridis, Brian D Juran, 2011, Seminars in liver disease.

International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways

Casey S. Greene, Marco Carbone, Andrew Fraser, 2015, Nature Communications.

Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants.

P. Gregersen, K. Siminovitch, C. Amos, 2012, Human molecular genetics.

Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci

Christian Gieger, Euijung Ryu, Andre Franke, 2011, Nature Genetics.

O5 PRIMARY SCLEROSING CHOLANGITIS FROM A GLOBAL PERSPECTIVE – A MULTICENTER, RETROSPECTIVE, OBSERVATIONAL STUDY OF THE INTERNATIONAL PSC STUDY GROUP

M. Manns, C. Strassburg, T. Karlsen, 2014 .

HLA haplotypes in primary sclerosing cholangitis patients of admixed and non‐European ancestry

T. Karlsen, B. Lie, A. Franke, 2017, HLA.

Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci.

C. Gieger, C. Wijmenga, M. Manns, 2012, Journal of hepatology.

Urinary Tract Infection and Risk of Primary Biliary Cirrhosis

K. Lazaridis, B. Juran, 2014 .

Genomic Studies of the Spleen Protein Tyrosine Kinase Locus Reveal a Complex Promoter Structure and Several Genetic Variants

F. Uckun, P. Goodman, C. M. Wood, 2002, Leukemia & lymphoma.

Genome-Wide Association Studies in Primary Biliary Cirrhosis

K. Lazaridis, B. Juran, A. Gulamhusein, 2015, Seminars in Liver Disease.

Questionnaire based assessment of risk factors for primary biliary cirrhosis.

J. Larson, E. Atkinson, C. Lammert, 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis

P. Gregersen, K. Siminovitch, C. Amos, 2010, Nature Genetics.

Genetics and genomics of primary biliary cirrhosis.

K. Lazaridis, B. Juran, 2008, Clinics in liver disease.

Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.

M. Manns, C. Strassburg, T. Karlsen, 2017, Gastroenterology.

Single-cell mass cytometry on peripheral blood identifies immune cell subsets associated with primary biliary cholangitis

J. Sung, J. Jang, Vinod Kumar Gupta, 2020, Scientific Reports.

Hypermethylation of the spleen tyrosine kinase promoter in T-lineage acute lymphoblastic leukemia

F. Uckun, P. Goodman, B. Juran, 2003, Oncogene.

High‐Resolution Exposomics and Metabolomics Reveals Specific Associations in Cholestatic Liver Diseases

Dean P. Jones, Megan M. Niedzwiecki, G. Gores, 2021, Hepatology communications.

The AmpliChip CYP450 test: principles, challenges, and future clinical utility in digestive disease.

K. Lazaridis, L. Egan, B. Juran, 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Environmental chemicals and endogenous metabolites in bile of USA and Norway patients with primary sclerosing cholangitis

A. Athreya, G. Gores, T. Karlsen, 2023, Exposome.

Primary biliary cirrhosis is associated with a genetic variant in the 3' flanking region of the CTLA4 gene.

B. Fridley, E. Atkinson, K. Lazaridis, 2008, Gastroenterology.

Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis

M. Manns, M. Silverberg, W. Lieb, 2017, Gut.

Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD

J. Tabibian, E. Atkinson, K. Lazaridis, 2016, American Journal of Gastroenterology.

Update on the genetics and genomics of PBC.

K. Lazaridis, B. Juran, 2010, Journal of autoimmunity.

Common Genetic Variation and Haplotypes of the Anion Exchanger SLC4A2 in Primary Biliary Cirrhosis

J. Larson, E. Atkinson, K. Lazaridis, 2009, The American Journal of Gastroenterology.

Interacting alleles of the coinhibitory immunoreceptor genes cytotoxic T‐lymphocyte antigen 4 and programmed cell‐death 1 influence risk and features of primary biliary cirrhosis

B. Fridley, G. Petersen, E. Atkinson, 2007, Hepatology.

Genetics of hepatobiliary diseases.

K. Lazaridis, B. Juran, 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Genetic polymorphisms of matrix metalloproteinase 3 in primary sclerosing cholangitis

A. Franke, J. Larson, D. Ellinghaus, 2011, Liver international : official journal of the International Association for the Study of the Liver.

External validation of the United Kingdom‐primary biliary cholangitis risk scores of patients with primary biliary cholangitis treated with ursodeoxycholic acid

M. de Andrade, E. Atkinson, K. Lazaridis, 2018, Hepatology communications.

Biochemical response to ursodeoxycholic acid predicts survival in a North American cohort of primary biliary cirrhosis patients

E. Atkinson, M. Andrade, L. Chan, 2014, Journal of Gastroenterology.

Low incidence of primary biliary cirrhosis (PBC) in the first‐degree relatives of PBC probands after 8 years of follow‐up

E. Atkinson, K. Lazaridis, B. Juran, 2016, Liver international : official journal of the International Association for the Study of the Liver.

P1152 : A Comparative study of pruritus in PBC cohorts from UK, USA and Italy

R. Sandford, G. Hirschfield, M. Carbone, 2015 .

Primary Sclerosing Cholangitis Risk Estimate Tool (PREsTo) Predicts Outcomes of the Disease: A Derivation and Validation Study Using Machine Learning

G. Gores, T. Karlsen, N. LaRusso, 2020, Hepatology.